-
Basi G, Schmid E, Maundrell K. 1993. TATA box mutations in the Schizosaccharomyces pombe nmt1 promoter affect transcription efficiency but not the transcription start point or thiamine repressibility. Gene, 123: 131-136.
doi: 10.1016/0378-1119(93)90552-E
-
Chang D D, Sharp P A. 1989. Regulation by HIV Rev depends upon recognition of splice sites. Cell, 59: 789-795.
doi: 10.1016/0092-8674(89)90602-8
-
Chatterji U, Grant C K, Elder J H. 2000. Feline immunodeficiency virus Vif localizes to the nucleus. J Virol, 74: 2533-2540.
doi: 10.1128/JVI.74.6.2533-2540.2000
-
Conticello S G, Harris R S, Neuberger M S. 2003. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr Biol, 13: 2009-2013.
doi: 10.1016/j.cub.2003.10.034
-
Dutko J A, Schafer A, Kenny A E, et al. 2005. Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. Curr Biol, 15: 661-666.
doi: 10.1016/j.cub.2005.02.051
-
Esnault C, Heidmann O, Delebecque F, et al. 2005. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature, 433: 430-433.
doi: 10.1038/nature03238
-
Feng F, Davis A, Lake J A, et al. 2004. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif. J Virol, 78: 10574-10581.
doi: 10.1128/JVI.78.19.10574-10581.2004
-
Gabuzda D H, Lawrence K, Langhoff E, et al. 1992. Role of Vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J Virol, 66: 6489-6495.
-
Goff S P. 2004. Retrovirus restriction factors. Mol Cell, 16: 849-859.
doi: 10.1016/j.molcel.2004.12.001
-
Goff S P. 2003. Death by deamination: A novel host restriction system for HIV-1. Cell, 114: 281-283.
doi: 10.1016/S0092-8674(03)00602-0
-
Goncalves J, Jallepalli P, Gabuzda D H. 1994. Subcellular localization of the Vif protein of human immunodeficiency virus type 1. J Virol, 68: 704-712.
-
Harris R S, Liddament M T. 2004. Retroviral restriction by APOBEC proteins. Nat Rev Immunol, 4: 868-877.
doi: 10.1038/nri1489
-
Hollams E M, Giles K M, Thomson A M, et al. 2002. mRNA stability and the control of gene expression: implications for human disease. Neurochem Res, 27: 957-980.
doi: 10.1023/A:1020992418511
-
Kao S, Khan M A, Miyagi E, et al. 2003. The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. J Virol, 77: 11398-11407.
doi: 10.1128/JVI.77.21.11398-11407.2003
-
Karczewski M K, Strebel K. 1996. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J Virol, 70: 494-507.
-
Kjems J, Askjaer P. 2000. Rev protein and its cellular partners. Adv Pharmacol, 48: 251-298.
doi: 10.1016/S1054-3589(00)48009-9
-
Liu B, Yu X, Luo K, et al. 2004. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G. J Virol, 78: 2072-2081.
doi: 10.1128/JVI.78.4.2072-2081.2004
-
Luo K, Xiao Z, Ehrlich E, et al. 2005. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc Natl Acad Sci USA, 102: 11444-11449.
doi: 10.1073/pnas.0502440102
-
Madani N, Millette R, Platt E J, et al. 2002. Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1. J Virol, 76: 11133-11138.
doi: 10.1128/JVI.76.21.11133-11138.2002
-
Maldarelli F, Martin M A, Strebel K. 1991. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J Virol, 65: 5732-5743.
-
Marin M, Rose K M, Kozak S L et al. 2003. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med, 9: 1398-1403.
doi: 10.1038/nm946
-
Maundrell K. 1990. nmt1 of fission yeast. A highly transcribed gene completely repressed by thiamine. J Biol Chem, 265: 10857-10864.
-
Maundrell K. 1993. Thiamine-repressible expression vectors pREP and pRIP for fission yeast. Gene, 123: 127-130.
doi: 10.1016/0378-1119(93)90551-D
-
Mehle A, Goncalves J, Santa-Marta M, et al. 2004. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APO-BEC3G degradation. Genes Dev, 18: 2861-2866.
doi: 10.1101/gad.1249904
-
Mehle A, Strack B, Ancuta P, et al. 2004. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway, J Biol Chem, 279: 7792-7798.
doi: 10.1074/jbc.M313093200
-
26. Wichroski M J, Ichiyama K, Rana T M. 2005. Analysis of HIV-1 Viral Infectivity Factor-mediated Proteasome-dependent Depletion of APOBEC3G. J Biol Chem, 280: 8387-8396.
doi: 10.1074/jbc.M408048200
-
Moreno S, Hayles J, Nurse, P. 1991. Molecular Genetic Analysis of Fission Yeast Schizosaccharomyces pombe. Methods Enzymol, 194: 795-823.
doi: 10.1016/0076-6879(91)94059-L
-
Santa-Marta M, da Silva F A, Fonseca A M, et al. 2005. HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid inter-action and without protein degradation. J Biol Chem, 280: 8765-8775.
doi: 10.1074/jbc.M409309200
-
Schneider R, Campbell M, Nasioulas G, et al. 1997. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J Virol, 71:4892-4903.
-
Schwartz S, Felber B K, Pavlakis G N. 1992. Distinct RNA sequences in the gag region of human immunode-ficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J Virol, 66: 150-159.
-
Simon J H, Carpenter E A, Fouchier R A, et al. 1999. Vif and the p55(Gag) polyprotein of human immunode-ficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes. J Virol, 73: 2667-2674.
-
Sova P, Volsky D J. 1993. Efficiency of viral DNA synthesis during infection of permissive and nonper-missive cells with Vif-negative human immunodeficiency virus type 1. J Virol, 67: 6322-6326.
-
Sreekrishna K, Brankamp R G, Kropp K E, et al. 1997. Subramaniam and L.A. Birkenberger, Strategies for optimal synthesis and secretion of heterologous proteins in the methylotrophic yeast Pichia pastoris. Gene, 190: 55-62.
doi: 10.1016/S0378-1119(96)00672-5
-
Stopak K, de Noronha C, Yonemoto W, et al. 2003. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell, 12: 591-601.
-
Turelli P, Mangeat B, Jost S, et al. 2004. Inhibition of hepatitis B virus replication by APOBEC3G. Science, 303: 1829.
doi: 10.1126/science.1092066
-
Wichroski M J, Ichiyama K, Rana T M. 2005. Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: Correlating function and subcellular localization. J Biol Chem, 280: 8387-8396.
doi: 10.1074/jbc.M408048200
-
Wiegand H L, Doehle B P, Bogerd H P, et al. 2004. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J, 23: 2451-2458.
doi: 10.1038/sj.emboj.7600246
-
Yu X, Yu Y, Liu B, et al. 2003.Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science, 302: 1056-1060.
doi: 10.1126/science.1089591
-
Yu Y, Xiao Z, Ehrlich E S, et al. 2004. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev, 18: 2867-2872.
doi: 10.1101/gad.1250204
-
Zhao Y, Cao J, O'Gorman M R, et al. 1996. Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe. J Virol, 70: 5821-5826.
-
Zhao Y, Elder R T, Chen M, et al. 1998. Fission yeast expression vectors adapted for positive identification of gene insertion and green fluorescent protein fusion.Biotechniques, 25: 438-440, 442, 444.
-
Zheng Y H, Irwin D, Kurosu T, et al. 2004. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J Virol, 78: 6073-6076.
doi: 10.1128/JVI.78.11.6073-6076.2004